Contineum Therapeutics In... (CTNM)
NASDAQ: CTNM
· Real-Time Price · USD
11.74
0.39 (3.44%)
At close: Oct 06, 2025, 10:11 AM
Contineum Therapeutics Class A Common Stock Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for CTNM stock have an median target of 20.5, with a low estimate of 16 and a high estimate of 23. The median target predicts an increase of 74.62% from the current stock price of 11.74.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 16 | 20 | 20.5 | 23 |
| Change | 36.29% | 70.36% | 74.62% | 95.91% |
Latest Analyst Insight Report
RBC Capital maintains an Outperform rating on Cont... Unlock content with Pro Subscription
Updated May 15, 2025
| Rating | Nov 24 | Jan 25 | Mar 25 | May 25 | Aug 25 | Sep 25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 2 | 2 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 2 | 1 | 1 |
Financial Forecast this Year
Revenue This Year
4.29M
from 0
Increased by n/a%
Revenue Next Year
1.88M
from 4.29M
Increased by -56.1%
EPS This Year
-2.35
from -2.18
Increased by -7.8%
EPS Next Year
-2.72
from -2.35
Increased by -15.7%